Tag: Nordisk
Biocorp: exclusive negotiations with Novo Nordisk
(CercleFinance.com) – Novo Nordisk has entered into exclusive negotiations with BIO JAG, main shareholder of Biocorp, with a view to purchasing its entire stake in Biocorp, representing 45.3% of the…
Novo Nordisk: Exclusive negotiations for Biocorp
(CercleFinance.com) – Novo Nordisk has entered into exclusive negotiations with BIO JAG, main shareholder of Biocorp, with a view to purchasing its entire stake in Biocorp, representing 45.3% of the…
Biocorp: Exclusive negotiations with Novo Nordisk
Read also (CercleFinance.com) – Novo Nordisk has entered into exclusive negotiations with BIO JAG, main shareholder of Biocorp, with a view to purchasing its entire stake in Biocorp, representing 45.3%…
Biocorp: exclusive negotiations with Novo Nordisk – 06/05/2023 at 08:09
(CercleFinance.com) – Novo Nordisk has entered into exclusive negotiations with BIO JAG, main shareholder of Biocorp, with a view to purchasing its entire stake in Biocorp, representing 45.3% of the…
Biocorp enters into exclusive negotiations with Novo Nordisk – 06/05/2023 at 08:35
(AOF) – Novo Nordisk has entered into exclusive negotiations with Bio Jag, main shareholder of Biocorp, with a view to purchasing its entire stake in Biocorp, representing 45.3% of the…
Novo Nordisk enters into exclusive negotiations for the acquisition of a controlling stake in BIOCORP, followed by a mandatory tender offer – 06/05/2023 at 07:00
• Novo Nordisk has entered into exclusive negotiations with BIO JAG, main shareholder of BIOCORP, with a view to purchasing its entire stake in BIOCORP, representing 45.3% of the share…
Novo Nordisk: R&D agreement with Life Edit Therapeutics
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Novo Nordisk: overwhelmed by demand for its anti-obesity
(CercleFinance.com) – Novo Nordisk announced on Friday that it would only be able to supply limited quantities of Wegovy, its obesity treatment which is enjoying growing success in the United…
Novo Nordisk: In the green with broker comments
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Novo Nordisk: In the green with a brokerage upgrade
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Novo Nordisk: agreement with Aspect in Stem Cells
(CercleFinance.com) – Novo Nordisk announced on Wednesday the signing of a partnership with the Canadian Aspect Biosystems providing for the granting of a license option on a technology for printing…
Novo Nordisk: Conclusive trial in type 2 diabetes
(CercleFinance.com) – Novo Nordisk announces that a phase 3b trial of oral semaglutide administered once daily at 25 mg and 50 mg in people with type 2 diabetes requiring treatment…